Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Semjonow

Showing results (81-90 of 102) with videos related to

Pageof 11
Sort By:
Scientific Reports|March 4, 2024
Critical evaluation of artificial intelligence as a digital twin of pathologists for prostate cancer pathologyOkyaz Eminaga, Mahmoud Abbas, Christian Kunder, et al.
European Urology Oncology|April 19, 2022
A Multivariable Approach Using Magnetic Resonance Imaging to Avoid a Protocol-based Prostate Biopsy in Men on Active Surveillance for Prostate Cancer-Data from the International Multicenter Prospective PRIAS StudyHenk Benjamin Luiting, Sebastiaan Remmers, Egbert R Boevé, et al.
JAMA Network Open|January 17, 2025
Personalized Dynamic Prediction Model for Biopsy Timing in Patients With Prostate Cancer During Active SurveillanceIvo I de Vos, Daan Nieboer, Mark Frydenberg, et al.
The Prostate|May 22, 2009
DNA methylation biomarkers of prostate cancer: confirmation of candidates and evidence urine is the most sensitive body fluid for non-invasive detectionShannon R Payne, Jurgen Serth, Martin Schostak, et al.
BJU International|January 15, 2016
Complications after prostate biopsies in men on active surveillance and its effects on receiving further biopsies in the Prostate cancer Research International: Active Surveillance (PRIAS) studyLeonard P Bokhorst, Inari Lepistö, Yoshiyuki Kakehi, et al.
Journal of Personalized Medicine|November 27, 2021
Low Tumor-to-Stroma Ratio Reflects Protective Role of Stroma against Prostate Cancer ProgressionPaulina Nastały, Julia Smentoch, Marta Popęda, et al.
British Journal of Cancer|September 9, 2020
EGFR as a stable marker of prostate cancer dissemination to bonesPaulina Nastały, Sara Stoupiec, Marta Popęda, et al.
European Urology Oncology|January 10, 2021
PROPOSe: A Real-life Prospective Study of Proclarix, a Novel Blood-based Test to Support Challenging Biopsy Decision-making in Prostate CancerThomas Steuber, Isabel Heidegger, Mona Kafka, et al.
World Journal of Urology|March 3, 2007
Assay-specific artificial neural networks for five different PSA assays and populations with PSA 2-10 ng/ml in 4,480 menCarsten Stephan, Chuanliang Xu, Henning Cammann, et al.
Clinical Chemistry|June 2, 2022
Expression Patterns and Corepressor Function of Retinoic Acid-induced 2 in Prostate CancerKatharina Besler, Aleksandra Węglarz, Laura Keller, et al.
Pageof 11

Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
Scientific Reports|March 4, 2024
Critical evaluation of artificial intelligence as a digital twin of pathologists for prostate cancer pathologyOkyaz Eminaga, Mahmoud Abbas, Christian Kunder, et al.
European Urology Oncology|April 19, 2022
A Multivariable Approach Using Magnetic Resonance Imaging to Avoid a Protocol-based Prostate Biopsy in Men on Active Surveillance for Prostate Cancer-Data from the International Multicenter Prospective PRIAS StudyHenk Benjamin Luiting, Sebastiaan Remmers, Egbert R Boevé, et al.
JAMA Network Open|January 17, 2025
Personalized Dynamic Prediction Model for Biopsy Timing in Patients With Prostate Cancer During Active SurveillanceIvo I de Vos, Daan Nieboer, Mark Frydenberg, et al.
The Prostate|May 22, 2009
DNA methylation biomarkers of prostate cancer: confirmation of candidates and evidence urine is the most sensitive body fluid for non-invasive detectionShannon R Payne, Jurgen Serth, Martin Schostak, et al.
BJU International|January 15, 2016
Complications after prostate biopsies in men on active surveillance and its effects on receiving further biopsies in the Prostate cancer Research International: Active Surveillance (PRIAS) studyLeonard P Bokhorst, Inari Lepistö, Yoshiyuki Kakehi, et al.
Journal of Personalized Medicine|November 27, 2021
Low Tumor-to-Stroma Ratio Reflects Protective Role of Stroma against Prostate Cancer ProgressionPaulina Nastały, Julia Smentoch, Marta Popęda, et al.
British Journal of Cancer|September 9, 2020
EGFR as a stable marker of prostate cancer dissemination to bonesPaulina Nastały, Sara Stoupiec, Marta Popęda, et al.
European Urology Oncology|January 10, 2021
PROPOSe: A Real-life Prospective Study of Proclarix, a Novel Blood-based Test to Support Challenging Biopsy Decision-making in Prostate CancerThomas Steuber, Isabel Heidegger, Mona Kafka, et al.
World Journal of Urology|March 3, 2007
Assay-specific artificial neural networks for five different PSA assays and populations with PSA 2-10 ng/ml in 4,480 menCarsten Stephan, Chuanliang Xu, Henning Cammann, et al.
Clinical Chemistry|June 2, 2022
Expression Patterns and Corepressor Function of Retinoic Acid-induced 2 in Prostate CancerKatharina Besler, Aleksandra Węglarz, Laura Keller, et al.
Pageof 11